**Core Concept**
Langerhan's cell histiocytosis (LCH) is a rare disorder characterized by the proliferation of Langerhan's cells, a type of dendritic cell found in the skin and other organs. This condition can lead to various clinical manifestations, including skin lesions, bone lesions, and organ dysfunction.

**Why the Correct Answer is Right**
The correct marker for Langerhan's cell histiocytosis is CD1a. CD1a is a surface antigen expressed on Langerhan's cells and is used as a diagnostic marker for LCH. This marker is essential for identifying LCH in skin biopsies and other tissues. The CD1a antigen is a member of the CD1 family, which plays a crucial role in the presentation of lipid antigens to T cells. In the context of LCH, the expression of CD1a helps to distinguish Langerhan's cells from other types of histiocytes.

**Why Each Wrong Option is Incorrect**
**Option A:** S-100 protein is a marker for melanocytic lesions and various types of tumors, but it is not specific for Langerhan's cell histiocytosis.
**Option B:** CD68 is a marker for histiocytes in general, but it is not specific for Langerhan's cells and can be expressed on other types of histiocytes.
**Option C:** HLA-DR is a marker for antigen-presenting cells, including Langerhan's cells, but it is not specific for LCH and can be expressed on other types of immune cells.

**Clinical Pearl / High-Yield Fact**
Langerhan's cell histiocytosis can present with a wide range of clinical manifestations, from skin lesions to multi-organ dysfunction. A high index of suspicion is necessary for diagnosis, and the use of CD1a as a diagnostic marker can aid in the identification of this condition.

**Correct Answer:** C. CD1a.